Type 2 Diabetes: New Treatment Trial Results
Clinical Trial — Recruiting Now
🔬 Active Clinical Trial: NCT07648615 | Status: NOT_YET_RECRUITING | Phase: NA
A New Trial Tests Electrical Stimulation Outside the Cochlea for Severe Tinnitus
Researchers at a single site in the Netherlands will soon test an unconventional method for quieting severe tinnitus: an extracochlear implant. A clinical trial listed as NCT07648615 will evaluate a new surgical procedure that places an electrode near the round window, just outside the cochlea. The primary goal is to suppress constant ringing or buzzing without harming the participant’s natural acoustic hearing. For patients with intractable tinnitus where other treatments have failed, this study represents a direct approach to modulating nerve signals before they reach the auditory processing centers of the brain.
The study, formally titled “Extracochlear Electrical Stimulation in Patients With Intractable Tinnitus – a Feasibility Study,” is specifically designed for individuals whose severe tinnitus has not improved with hearing aids or standard clinical care. The rationale is based on a principle familiar in tinnitus research: abnormal neuronal hyperactivity in the auditory pathway can be influenced by targeted electrical stimulation. By keeping the stimulating electrode outside the delicate, fluid-filled cochlea, scientists aim to provide therapeutic stimulation while avoiding the inner ear damage that can sometimes occur with fully inserted cochlear implant electrodes.
Key Takeaways
- The study is testing an electrode placed outside the cochlea (extracochlear) to suppress tinnitus while preserving natural hearing.
- It is designed for a very specific group: adults with severe, one-sided tinnitus and high-frequency hearing loss who have found no relief from other treatments.
- Participation involves two surgical stages: a screening under local anesthesia, followed by full implantation if the screening is successful.
- This is a small, early-stage feasibility study enrolling only 6 participants to assess safety and initial efficacy.
- Success could lead to a new surgical option for tinnitus patients for whom sound-based therapies and hearing aids have been ineffective.
How the Trial Will Work
This prospective, interventional study has a straightforward pre-post design. All participants will undergo the same procedures, and outcomes will be measured by comparing their condition before and after implantation.
The process involves two distinct phases. First, each participant will have a screening procedure performed under local anesthesia. During this session, researchers will temporarily insert a test electrode. The goal is to see if external electrical stimulation at that specific location provides immediate tinnitus suppression. If it does not, the study ends for that individual, and the electrode is removed.
For those who respond positively to the screening stimulation, the study proceeds to the second phase: a full implantation surgery under general anesthesia. In this operation, a cochlear implant device will be placed, but its electrode array will be positioned outside the cochlea, in the vicinity of the round window. After surgery, participants will have a series of medical check-ups. Researchers will then measure the safety and effectiveness of the chronic stimulation, focusing on two primary outcomes: the level of tinnitus suppression and any changes in speech perception.
Who Is Eligible to Participate?
The eligibility criteria are strict, defining a very specific patient population. Participants must be at least 18 years old, proficient in Dutch, and have suffered from severe, unilateral tinnitus for a minimum of one year.
The severity is quantified using standardized questionnaires. Eligible individuals must have a Tinnitus Functionality Index (TFI) global score of 54 or above and a Tinnitus Questionnaire (TQ) global score of 47 or above. They must also have high-frequency sensorineural hearing loss in the ear to be treated. Critically, they must have already tried and found no relief from standard clinical tinnitus treatments, including hearing aids. They must also be physically able to undergo the surgery and participate in the required rehabilitation program.
The exclusion criteria are designed to ensure safety and result clarity. Individuals with chronic middle ear pathology are excluded. Anatomical factors that might not allow for safe or effective implantation will also rule out participation, as will certain other unspecified surgical and medical conditions listed in the full trial protocol.
The Scientific Basis and Current Status
The scientific premise builds on decades of evidence showing that the auditory system can be influenced by electrical stimulation. Cochlear implants, for example, often incidentally reduce tinnitus in deafened ears. The novel aspect of this trial is the deliberate placement of the stimulating electrode in an extracochlear position. This targets the auditory nerve fibers indirectly, potentially reducing the risk of inner ear damage and preserving any remaining natural hearing—a significant concern for many patients with tinnitus who have residual hearing.
The trial’s current status is “NOT_YET_RECRUITING.” It is designated as a feasibility study and does not have a formal phase label (NA). The planned enrollment is small, with only six participants. This size is typical for an early-stage investigation, where the focus is on procedural safety, tolerability, and gathering initial proof-of-concept data rather than large-scale statistical outcomes.
Potential Impact on Patients and Hearing Health
If the extracochlear stimulation proves to be safe and effective, it could establish a new direction for treating severe, drug-resistant tinnitus. The approach offers a more targeted alternative to sound-based therapies like maskers or hearing aids, which do not work for everyone. It also presents a potentially less invasive option than deep brain stimulation or other neuro-modulatory surgeries used in extreme cases.
For the field of tinnitus research, successful results would provide direct evidence that stimulation outside the cochlea can modulate the phantom sound percept. This would help refine models of where and how tinnitus is generated in the auditory pathway. Data on speech perception outcomes will also be valuable, indicating whether this specific form of stimulation interferes with, preserves, or even enhances the processing of real external sounds.
As with all early-stage trials, significant work would remain after this study. Positive findings would need to be replicated in larger, controlled trials with longer follow-up periods to understand the long-term benefits and risks. However, for individuals living with a severe, unrelenting tinnitus signal that dominates their daily life, this study represents a concrete step toward a new type of solution.
This article is for informational purposes only. Consult a qualified professional for personalised advice.
Source:
Efficacy of a Tinnitus Implant for People With Severe Tinnitus Without Damaging the Acoustic Hearing. (ClinicalTrials.gov: NCT07648615)
Medical Disclaimer
This article is for informational purposes only and does not constitute medical advice. The research summaries presented here are based on published studies and should not be used as a substitute for professional medical consultation. Always consult a qualified healthcare provider before making any changes to your health regimen.
Peer-reviewed health research, simplified. Early access findings, clinical trial alerts & regulatory news — delivered weekly.
No spam. Unsubscribe anytime. Powered by Beehiiv.
Related Research
From Our Research Network
Exercise & metabolic fitnessSleep Science
Sleep & circadian healthPet Health
Veterinary scienceHealthspan Click
Longevity scienceBreathing Science
Respiratory healthMenopause Science
Hormonal health researchParent Science
Child development researchGut Health Science
Microbiome & digestive health
Part of the Evidence-Based Research Network
